Synonym |
Cys(NPys)-Antennapedia Homeobox (43-58) amide |
Species |
Human |
Protein Accession |
P25323 |
Purity |
≥95% |
Endotoxin Level |
<1.0 EU per µg |
Biological Activity |
Not specified |
Expression System |
Not specified |
Fusion Tag |
None |
Predicted Molecular Mass |
3.8 kDa |
Formulation |
Supplied as a lyophilized powder |
Reconstitution |
Centrifuge vial before opening. Reconstitute in sterile ddH2O or aqueous buffer containing 0.1%
BSA to a concentration of 0.1-1.0 mg/ml. |
Storage & Stability |
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12
months. |
FAQ
What is Cys(NPys)-Antennapedia Homeobox (43-58) amide, and how does it work in biological
systems?
Cys(NPys)-Antennapedia Homeobox (43-58) amide is a synthetic variant of the Antennapedia
homeodomain peptide, known for its ability to transport molecules across cellular membranes. The
homeodomain itself is a domain in proteins that binds DNA, mostly involved in regulating the expression
of genes responsible for the development and differentiation of tissues in the organism. This synthetic
derivative has been designed to facilitate the delivery of bioactive molecules into cells, enhancing the
bioavailability and efficacy of therapeutic agents.
The inclusion of the Cys(NPys) component is
crucial as it provides a reactive thiol group that can form disulfide bridges. These bridges can
covalently link with other molecules, modifying or enhancing the biological properties of the peptide.
This particular sequence (43-58) suggests it has been optimized for specific interaction capabilities,
likely increasing its affinity for cell surface receptors or enhancing stability in biological
environments.
Once the molecule enters a biological system, it utilizes the inherent properties
of the Antennapedia homeodomain to penetrate cell membranes. This translocation is non-invasive, meaning
it does not damage the cellular structure, thereby preserving normal cellular function and reducing
potential cytotoxicity. After crossing the membrane barrier, the Cys(NPys)-Antennapedia is released into
the cytoplasm, where it can deliver its molecular cargo for therapeutic action or diagnostic purposes.
This mechanism is particularly important in drug delivery systems, where effective
transportation of drugs directly into cells can significantly enhance their action, reduce dosages, and
minimize side effects. In research settings, it is also employed for genetic studies, as its ability to
penetrate cells can serve as a carrier for nucleic acids, facilitating the study of gene expression,
regulation, and function.
What makes Cys(NPys)-Antennapedia Homeobox (43-58) amide superior as a
delivery vehicle in therapeutic applications?
Cys(NPys)-Antennapedia Homeobox (43-58) amide is
regarded as an advanced cellular delivery vehicle due to its highly efficient translocation ability,
versatility, and biocompatibility. Firstly, its ability to traverse cellular membranes without
disrupting them is a significant advantage, setting it apart from traditional methods that can often be
invasive or cause cellular damage. The natural translocation strategy of the Antennapedia peptide
circumvents mechanisms that degrade or eliminate foreign molecules, enhancing system retention and
cellular uptake without triggering an immune response.
Secondly, the versatility of
Cys(NPys)-Antennapedia lies in its structural innovations. By including the Cys(NPys) moiety, this
molecule is equipped with a reactive component that forms disulfide bonds with other molecular species.
This feature is instrumental when conjugating therapeutic agents, allowing it to carry a diverse range
of bioactive molecules, from small drugs to larger nucleotides and proteins. Thus, researchers and
pharmaceutical developers can employ it in various therapeutic environments, adapting it to the
requirements of the transported molecule.
Additionally, the sequence (43-58) optimization means
the molecule has been designed for maximum efficiency in traversing specific cellular types or tissues,
making it a valuable component of targeted therapy approaches. By honing its affinity to particular
cellular environments, the efficacy of treatments is increased, focusing drug actions where they are
most needed while minimizing systemic spread and unnecessary exposure.
Another key aspect is its
biocompatibility. Unlike artificial delivery systems that risk being seen as foreign by the body’s
defense mechanisms, Cys(NPys)-Antennapedia leverages nature’s own cell-penetrating approaches, reducing
immunogenicity and enhancing safety profiles. This is critical in clinical settings, where reducing
adverse reactions is equally as important as ensuring therapeutic efficacy.
Furthermore, the
stability conferred by this peptide in biological fluids ensures that it is robust enough to withstand
the systemic conditions until it reaches the target cells, maintaining its structure and function
throughout its journey. This characteristic significantly reduces the likelihood of premature
degradation, enhancing the reliability and predictability of therapeutic outcomes.
In conclusion,
the superior attributes of Cys(NPys)-Antennapedia Homeobox (43-58) amide as a delivery vehicle stem from
its strategic design that maximizes efficiency, adaptability, and safety, making it a contemporary
choice for advanced therapeutic and diagnostic applications.
How does the inclusion of the
Cys(NPys) group affect the functionality of Antennapedia Homeobox (43-58) amide?
The inclusion of
the Cys(NPys) group significantly enhances the functionality and versatility of the Antennapedia
Homeobox (43-58) amide, primarily through its capacity to form stable and reversible disulfide bonds.
This feature allows the peptide to act as a molecular carrier capable of forming conjugates with
therapeutic or diagnostic agents. The specific chemistry of the Cys(NPys) group introduces a reactive
thiol that can readily interact with cysteine residues on other molecules, facilitating the attachment
of a variety of molecular entities. This conjugation process is not only efficient but can also be
tailored to ensure the specific release of the cargo within targeted cellular environments or under
particular conditions within the biological milieu.
Furthermore, the additional bulk and
hydrophobicity introduced by the Cys(NPys) group can influence the peptide's interaction with the lipid
components of cell membranes. This affects the translocation efficiency, potentially increasing the
peptide's ability to penetrate cells by altering its interaction profile with membrane lipids or
proteins. Such interactions can stabilize specific secondary structures necessary for effective membrane
crossing, thereby improving cellular uptake of both the peptide and its cargo.
Moreover, the
presence of the Cys(NPys) group may contribute to the peptide's specificity and affinity for certain
cells or tissues. This is particularly important in targeted drug delivery, where therapeutic agents
need to reach specific sites of action while minimizing exposure to non-targeted areas, thus reducing
possible side effects. By adjusting the chemical environment around the reactive site, the Cys(NPys)
group can potentially alter the overall biodistribution and pharmacokinetic profile of the conjugated
agent.
In addition to these functional enhancements, the Cys(NPys) group provides additional
stabilization to the peptide. The disulfide bonds formed are typically stable under physiological
conditions but can be reductively cleaved in the more reductive intracellular environment. This precise
modulation of bond formation and cleavage allows the controlled release of the bioactive agent within
specific cellular compartments or contexts, providing strategic release profiles critical for
therapeutic success.
Lastly, this strategic incorporation broadens the scope for subsequent
modifications or functionalization of the peptide, allowing researchers to further customize the
molecule for innovative applications. Whether for increasing solubility, extending serum half-life, or
attaching additional functional groups or tags for monitoring and tracking, the Cys(NPys) group serves
as a key enabler in the adaptable design of functionalized peptides for research and clinical
applications.
What potential applications does Cys(NPys)-Antennapedia Homeobox (43-58) amide have
in biomedical research?
Cys(NPys)-Antennapedia Homeobox (43-58) amide holds tremendous potential
in a variety of biomedical research applications due to its efficient cell-penetrating capabilities and
modular design for molecular conjugation. Its potential roles span across drug delivery, gene therapy,
diagnostic imaging, and therapeutic agent development, becoming instrumental in advancing precision
medicine and personalized therapeutic strategies.
In drug delivery, this peptide can be utilized
as a vector to ferry small molecules or therapeutic agents directly into cells. This attribute is
particularly beneficial for drugs with intracellular targets that traditionally struggle with cellular
uptake due to the lipophilic nature of cell membranes. The Cys(NPys)-Antennapedia can conjugate
therapeutic molecules through disulfide bonds, ensuring that drugs are delivered efficiently into the
target cells. This could notably increase the efficacy of chemotherapeutic agents, allowing for reduced
dosages and minimized side effects, beneficial for comprehensive cancer treatment strategies.
In
terms of gene therapy, the Cys(NPys)-Antennapedia Homeobox can serve as an efficient delivery system for
nucleotides, such as DNA, RNA, or oligonucleotides, facilitating the study of gene expression and
regulation. The ability of this peptide to deliver genetic material into cells reliably could contribute
significantly to genetic engineering, RNA interference therapies, and CRISPR-Cas9 gene-editing
technology, advancing these fields by ensuring efficient delivery of necessary components to the target
cells.
Furthermore, Cys(NPys)-Antennapedia can be employed in diagnostic imaging, where it could
carry imaging agents inside cells for enhanced cellular or tissue imaging. The ability to target and
penetrate specific cell types means that labeled versions of this peptide could deliver fluorophores,
radiolabels, or MRI contrast agents directly to the cell's interior, improving imaging resolution and
accuracy. This would provide more detailed insights into cellular functions and pathological states,
which is crucial for both research and clinical diagnostic processes.
Additionally, the peptide's
ability to target specific cells raises opportunities in regenerative medicine, where it can facilitate
the targeted delivery of factors that induce specific cellular pathways or differentiation processes,
crucial for tissue engineering and repair.
Finally, by serving as a platform for therapeutic
development, Cys(NPys)-Antennapedia can facilitate the exploration of new therapeutic targets and the
creation of novel treatment modalities. Its adaptability and specificity in delivering active substances
into cells open new avenues in drug development pipelines, offering the potential for creating
sophisticated, targeted therapies tailored for diverse medical conditions, including those currently
difficult to treat with existing delivery systems.
How does Cys(NPys)-Antennapedia Homeobox
(43-58) amide differ from traditional vectors or carriers used in drug
delivery?
Cys(NPys)-Antennapedia Homeobox (43-58) amide represents a novel category of drug
delivery vehicles distinguished from traditional vectors or carriers due to its unique biochemical
properties, mechanisms of action, and advantages related to efficacy and safety. The fundamental
difference lies in its cell-penetrating nature through a naturally derived peptide sequence optimized
for crossing cell membranes without inducing cytotoxicity or immune activation.
Traditional drug
delivery systems, such as liposomes, nanoparticles, or viral vectors, often rely on encapsulating agents
within biocompatible materials or genetic modification for systemic circulation to improve delivery
efficiency. These methods, although useful, frequently present several challenges, including potential
immunogenic responses, issues with endosomal escape, limited tissue affinity, residual toxicity, and
difficulty in achieving precise targeting without affecting non-targeted cells.
In contrast,
Cys(NPys)-Antennapedia Homeobox acts as a non-invasive cellular penetrating peptide (CPP), leveraging
its specific sequence to directly traverse cell membranes, transporting molecular cargo simply and
efficiently. This intrinsic ability is facilitated by mechanisms that exploit fundamental membrane
translocation processes, such as direct penetration or receptor-mediated uptake, without compromising
cellular integrity or triggering inflammatory pathways. This is particularly advantageous in clinical
applications where minimizing additional immune stimulation is critical for patient
safety.
Moreover, the presence of the Cys(NPys) moiety elevates Cys(NPys)-Antennapedia by
enabling it to form covalent bonds with drugs or therapeutic agents, offering a stable yet reversible
loading method that enhances cargo control and release. Such an approach surpasses conventional methods
which may rely on non-covalent interactions often susceptible to premature dissociation in biological
environments.
Additionally, compared to viral vectors commonly used in gene therapy,
Cys(NPys)-Antennapedia eliminates complexities associated with genetic components, such as insertional
mutagenesis and viral replication. Its peptide nature avoids integration into host genomes, ensuring
safer therapeutic interventions.
The size and structural flexibility of Cys(NPys)-Antennapedia
also lend themselves to more efficient clearance from the body, reducing potential complications
associated with accumulation or extended retention seen with bulkier nanoparticles. This ensures
favorable pharmacokinetic properties, promoting rapid uptake and proper excretion post therapy, lending
itself to repeated or prolonged treatment regimens without adverse buildup.
Ultimately,
Cys(NPys)-Antennapedia Homeobox (43-58) amide's inherent cellular entry strategy, coupled with scaffold
adaptability, sets it apart as a refined mechanism for addressing delivery challenges, presenting a
highly efficient, versatile, and safer alternative to more conventional drug delivery systems.